News / 22 Jun 2022
Summit Therapeutics Announces $100 Million Rights Offering
News / 03 Jun 2022
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
News / 01 Jun 2022
Summit Therapeutics Appoints Ankur Dhingra as Chief Financial Officer
We are building a very differentiated company that focuses on bringing innovation to the treatment of high unmet medical needs by focusing on the cause of the condition and sparing the rest of the incredible ecosystem that is the human body. Precision-targeting agents will be the new standards of care because they benefit patients and healthcare providers by minimizing trauma while curing the disease, which, in turn, creates value for society and payers alike.
Chairman & Chief Executive Officer